Take the first steps toward a new you today
Table of Contents: What is the difference between GLP-1 and Ozempic in terms of their uses
Weina H, Yuhu N, Christian H, Birong L, Feiyu S, Le W (2018) Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity
Ideal candidates typically have a BMI of 30 or higher, or a BMI of 27 or higher with additional health concerns such as high blood pressure, type 2 diabetes, or high cholesterol
The results of the phase 3a PIONEER TEENS study will underpin filings of the drug under the Ozempic and Rybelsus brand names before the end of 2026, and according to Novo Nordisk could become the first oral GLP-1 therapies approved for use in paediatric T2D patients